The CHIC in­ter­view: Stéphane Ban­cel on Mod­er­na's overnight trans­for­ma­tion, the new time­line on vac­cine de­vel­op­ment and his one re­gret in 2020

The Chi­na Health­care In­vest­ment Con­fer­ence — bet­ter known as CHIC — took place last week in Shang­hai at the Ritz-Carl­ton Pudong. End­points part­nered with CHIC this year in an ef­fort to high­light the glob­al na­ture of drug de­vel­op­ment, and John Car­roll con­duct­ed two vir­tu­al “fire­side chats” that was broad­cast to at­ten­dees. We’ll be shar­ing both with the End­points Pre­mi­um au­di­ence, and first up is a one-on-one in­ter­view with Mod­er­na’s Stéphane Ban­cel.

John Car­roll has been cov­er­ing Mod­er­na and Ban­cel since the very be­gin­ning. He start­ed their con­ver­sa­tion by not­ing it was the first time he’s tak­en a drug from a com­pa­ny he’s cov­ered from its in­cep­tion. They go on to dis­cuss how Mod­er­na is be­ing trans­formed by cash-flow ear­li­er than ex­pect­ed, Ban­cel’s one big re­gret in 2020, and much more.

Their con­ver­sa­tion is be­low, and we hope you en­joy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER